Ignite Creation Date:
2024-05-06 @ 1:04 AM
Last Modification Date:
2024-10-26 @ 10:58 AM
Study NCT ID:
NCT01723085
Status:
TERMINATED
Last Update Posted:
2018-07-30
First Post:
2012-11-05
Brief Title:
Anti-Mullerian Hormone Levels Before and After an Open Myomectomy
Sponsor:
Clinique Ovo
Organization:
Clinique Ovo
Study Overview
Official Title:
Anti-Mullerian Hormone Levels Variations Following an Open Myomectomy
Status:
TERMINATED
Status Verified Date:
2018-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
It has been put on hold for the moment due to logistic problems
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Anti-Mullerian hormone AMH is a marker for ovarian reserve It is well known that ovarian surgery for endometriosis lowers Anti-Mullerian hormone but little is known for other surgeries We seek to investigate the hormone variations before and after an open myomectomy
Hypothesis Anti-Mullerian hormone levels drop following surgery but return to normal levels in a few months
Hypothesis Anti-Mullerian hormone levels drop following surgery but return to normal levels in a few months
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None